Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The global population at risk from mosquito-borne diseases - including yellow fever, Zika and dengue - is expanding with changes in the distribution of two key mosquitoes: Aedes aegypti and Aedes albopictus. The spread of these species is largely driven by a combination of factors: human movements and climate change.

© Shutterstock

Now, with an unprecedented level of accuracy, an international team of researchers, led by Dr Moritz Kramer at the University of Oxford’s Department of Zoology, have used statistical mapping techniques to predict where the species will spread over an immediate, medium and long-term time-scale. Published in Nature Microbiology they pinpoint this information with the precision of 5x5 km.

The researchers have used 35 years of historic data, together with 17 of the highest-regarded and accepted climate change models to create a tool for public health officials which will allow them to target resource most efficiently and effectively to combat disease outbreak.

Read more (University of Oxford website)

Similar stories

Regular meat consumption linked with a wide range of common diseases

Research

Regular meat consumption is associated with a range of diseases that researchers had not previously considered, according to a large, population-level study conducted by a team at the University of Oxford.

New data show vaccines reduce severe COVID-19 in older adults

Coronavirus COVID-19 Research

New data show both Oxford / AstraZeneca vaccine and the Pfizer-BioNTech vaccines significantly reduce severe COVID-19 in older adults.

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

Coronavirus COVID-19 General Research

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.